首页> 外文期刊>Medicines >Clinical and Basic Studies on Therapeutic Efficacy of Herbal Medicines against Mycobacterial Infections
【24h】

Clinical and Basic Studies on Therapeutic Efficacy of Herbal Medicines against Mycobacterial Infections

机译:中草药对分枝杆菌感染的治疗作用的临床和基础研究

获取原文
       

摘要

The high incidence of tuberculosis (TB) in developing countries, the resurgence of TB in industrialized countries, and the worldwide increase in the prevalence of Mycobacterium avium complex infections are important global health concerns. However, the development of novel antimycobacterial drugs is currently making very slow progress. Therefore, it is considered that devising improved administration protocols for clinical treatment against intractable mycobacteriosis using existing chemotherapeutics is more practical than awaiting the development of new antimycobacterial drugs. The regulation of host immune responses using immunoadjunctive agents may increase the efficacy of antimicrobial treatment against mycobacteriosis. In particular, the mild and long-term up-regulation of host immune reactions against mycobacterial pathogens using herbal medicines may be beneficial for such immunoadjunctive therapy. This review focuses on the current status regarding basic and clinical studies on protocols using herbal medicines, including medicinal plants, useful for the clinical treatment of intractable mycobacterial infections.
机译:在发展中国家,结核病的高发病率,在工业化国家中结核病的复发以及全世界禽鸟分枝杆菌复合感染的流行率上升都是重要的全球健康问题。但是,新型抗分枝杆菌药物的开发目前进展非常缓慢。因此,认为与使用新的抗分枝杆菌药物的开发相比,使用现有的化学疗法设计针对临床上针对顽固性分枝杆菌病的临床治疗的改进的给药方案更为实际。使用免疫辅助剂调节宿主免疫应答可以提高抗分枝杆菌病的抗菌治疗的功效。尤其是,使用草药温和长期上调针对分枝杆菌病原体的宿主免疫反应的宿主免疫反应可能对此类免疫辅助治疗有益。这篇综述的重点是有关使用草药(包括药用植物)进行治疗的协议的基础和临床研究的当前状况,这些药物可用于治疗难治性分枝杆菌感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号